CISA urges immediate patching of critical remote code execution vulnerability in Eppendorf BioFlo 320 bioreactor systems, which could allow attackers to manipulate laboratory experiments and steal sensitive research data.
Eppendorf BioFlo 320 bioreactor systems are vulnerable to a critical remote code execution flaw that could allow attackers to manipulate laboratory experiments and steal sensitive research data. The vulnerability affects all firmware versions prior to 2.1.5.
CVE-2023-4527 has been assigned to this vulnerability, which carries a CVSS score of 9.8 (Critical). Exploitation does not require authentication, making the vulnerability particularly dangerous for organizations connected to the internet.
The vulnerability exists in the web interface component of the BioFlo 320 control software. Improper input validation in the parameter handling mechanism allows attackers to execute arbitrary code with root privileges on the device.
Attackers could exploit this vulnerability to:
- Manipulate bioreactor parameters affecting ongoing experiments
- Access and steal sensitive research data
- Deploy ransomware targeting laboratory infrastructure
- Gain initial access to internal networks for lateral movement
Eppendorf has released firmware version 2.1.5 to address this vulnerability. Organizations should immediately patch all affected BioFlo 320 systems.
Mitigation steps:
- Apply firmware update version 2.1.5 or later
- Place vulnerable systems in isolated network segments
- Implement firewall rules to restrict access to the BioFlo 320 web interface
- Change default credentials
- Monitor system logs for suspicious activity
Timeline:
- Vulnerability discovered: June 2023
- Vendor notified: July 3, 2023
- Patch released: September 15, 2023
- Public disclosure: October 2, 2023
Organizations unable to immediately patch should implement network segmentation and access controls as temporary measures until the patch can be applied.
For more information, visit the Eppendorf security advisory page and the CISA KEV catalog.
Comments
Please log in or register to join the discussion